東京呼吸器Doktor(@ZhgNHUVKOZq0IYN) 's Twitter Profile Photo

ASCO #8512 PEARLS/KEYNOTE-091
肺癌術後にキイトルーダ1年間のデータ。IMpower010と比べてどうかという話になるが。プラチナ入ってない人が14%程度いる。残りの8割弱のうちCDDPベースが5割程度。IMpowerとはだいぶ患者背景が違うので直接の評価は困難。
#ASCO22 #肺癌 #術後 #キイトルーダ

ASCO #8512 PEARLS/KEYNOTE-091 
肺癌術後にキイトルーダ1年間のデータ。IMpower010と比べてどうかという話になるが。プラチナ入ってない人が14%程度いる。残りの8割弱のうちCDDPベースが5割程度。IMpowerとはだいぶ患者背景が違うので直接の評価は困難。
#ASCO22  #肺癌 #術後 #キイトルーダ
account_circle
Natera Oncology(@NateraOncology) 's Twitter Profile Photo

The question persists: Which patients benefit from adjuvant ?

Hear Benjamin Weinberg, MD, FACP share his experience and perspective on the importance of personalized testing in providing insight into patient management

account_circle
Imperial Prostate(@IP_London) 's Twitter Profile Photo

🎤 GU Cast caught up with Hashim U. Ahmed @ Declan Murphy Renu Eapen GU Cast | Urology podcast!

A MRI compared to PSA could lead to more men diagnosed w/ significant cancer w/o increasing the number of men recommended to have a biopsy or over-diagnosed w/ insignificant cancer

account_circle
Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo

Immune cell differences between patients in different stages of monoclonal plasma cell disorders - Ho et al. Abstract 8065 meetings.asco.org/abstracts-pres…

Immune cell differences between patients in different stages of monoclonal plasma cell disorders - Ho et al. #ASCO22 Abstract 8065 meetings.asco.org/abstracts-pres… #ImmunoOnc #mmsm
account_circle
Megsie(@warriormegsie) 's Twitter Profile Photo

It was a BIG year in cancerland because I got to meet some of y’all IRL at , , and ! PLUS, I has amazing opportunities as just plain ‘ole ME, the and true Nut-Meg! Here's a snapshot of my 2022!

account_circle
AORTIC(@AORTIC_AFRICA) 's Twitter Profile Photo

We are excited to present the 2nd edition of the Best of ASCO Africa today! An opportunity for African Oncology Worksforce who were unable to attend the ASCO Annual Meeting to hear the very best of what was presented at ASCO22.
Registration is free!
👇🌍🔬

We are excited to present the 2nd edition of the Best of ASCO Africa today! An opportunity for African Oncology Worksforce who were unable to attend the ASCO Annual Meeting to hear the very best of what was presented at ASCO22.
Registration is free!
👇🌍🔬
account_circle
Emanuela Ferraro, MD(@EmaFer_90) 's Twitter Profile Photo

Endocrine therapy:Maverick! What's new in ER+ breast cancer? A lot cooking: oral SERD/SERCA/PROTAC..Our vision along with pivotal data in the field here (updated ASCO22)
📍cancertreatmentreviews.com/article/S0305-… Memorial Sloan Kettering Cancer Center production Komal Jhaveri @chandarS_mskcc Elaine Walsh

Endocrine therapy:Maverick! What's new in ER+ breast cancer? A lot cooking: oral SERD/SERCA/PROTAC..Our vision along with pivotal data in the field here (updated ASCO22)
📍cancertreatmentreviews.com/article/S0305-… @MSKCancerCenter production @jhaveri_komal @chandarS_mskcc @elaine1walsh #bcsm
account_circle
Dana-Farber’s Breast Oncology Center(@DFCI_BreastOnc) 's Twitter Profile Photo

Join Nancy Lin, MD and Paolo Tarantino on Wed Sept 7th as they discuss the outcomes of a recent study on metastatic presented at .
Register for the webinar here: dfci.zoom.us/webinar/regist…

Join @nlinmd and @PTarantinoMD on Wed Sept 7th as they discuss the outcomes of a recent study on #HER2low metastatic #BreastCancer presented at #ASCO22. 
Register for the webinar here: dfci.zoom.us/webinar/regist…
account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

32 panelists from 9 countries, 20 statements, one year of intense work (ASCO22->ASCO23).

I’m deeply honored to share the results of the first ever Consensus on HER2-low breast cancer, supported by ESMO and now published on Annals of Oncology. Read it here: annalsofoncology.org/article/S0923-…

32 panelists from 9 countries, 20 statements, one year of intense work (ASCO22->ASCO23). 

I’m deeply honored to share the results of the first ever Consensus on HER2-low breast cancer, supported by ESMO and now published on @Annals_Oncology. Read it here: annalsofoncology.org/article/S0923-…
account_circle
TARGED(@WebTarged) 's Twitter Profile Photo

18 Ekim, Salı Saat: 19.00-20.00 arasında gerçekleşecek 'ESMO ve ASCO 2022 Verileri ile Metastatik RCC' canlı yayınımıza bekleriz. Canlı yayın için; webtarged.org

18 Ekim, Salı Saat: 19.00-20.00 arasında gerçekleşecek 'ESMO ve ASCO 2022 Verileri ile Metastatik RCC' canlı yayınımıza bekleriz. Canlı yayın için; webtarged.org
#kanser #onkoloji #tumor #renalhucrelikanser #ESMO22 #ASCO22 #tedavi #erkenteshishayatkurtarir #farkindaol
account_circle
Black Women In Oncology Inc.(@WomenOncologist) 's Twitter Profile Photo

Meet the Distinguished Coral Olazagasti, MD ,an Outstanding Assistant Professor at the Sylvester Cancer Center, University of Miami UMiami Health System .A trailblazer in head , neck & thoracic , trained Northwell Health presented ASCO & ASCOPost .

Meet the Distinguished Coral Olazagasti, MD ,an Outstanding Assistant Professor at the Sylvester Cancer Center, @univmiami   @UMiamiHealth .A trailblazer in head , neck & thoracic #cancerresearch , trained @NorthwellHealth  presented   @ASCO  & @ASCOPost . #honoringicons #ASCO22
account_circle
Etienne Brain(@EtienneB66) 's Twitter Profile Photo

Fantastic honour to have received in Chicago the BJ Kennedy award from the ASCO Past President Dr Howard A Burris III. Thx ASCO for this persistent support to the underserved older patients with cancer ASCO SIOG Unicancer EORTC Institut Curie SoFOG

Fantastic honour to have received in Chicago the BJ Kennedy award from the ASCO Past President Dr Howard A Burris III. Thx ASCO for this persistent support to the underserved older patients with cancer @ASCO @SIOGorg @GroupeUnicancer @EORTC @institut_curie @sofog_officiel #ASCO22
account_circle